教室紹介

2016年業績集

受賞

  1. Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K., Kihara K. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease, "Best Poster Presentation", The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  2. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis, "Best Poster Presentation", The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  3. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy, "Best Poster Presentation", The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

原著

  1. Nakayama T, Numao N, Yoshida S, Ishioka J, Matsuoka Y, Saito K, Fujii Y, Kihara K. A novel interactive educational system in the operating room--the IE system. BMC Med Educ, 16(44), 2016.PubMed

  2. Kanda T, Fukuda S, Fukui N, Ohkubo Y, Kazumoto T, Saito Y, Ishikawa A, Kurosumi M, Kageyama Y, Fujii Y, Kihara K. Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer. Int J Clin Oncol, 21(4): 764-72, 2016.PubMed

  3. Kawamura N, Yokoyama M, Fujii Y, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal study. Int J Urol, 23(3): 219-23, 2016.PubMed

  4. Kawano S, Komai Y, Ishioka J, Sakai Y, Fuse N, Ito M, Kihara K, Saito N. Development of prognostic model for predicting survival after retrograde placement of ureteral stent in advanced gastrointestinal cancer patients and its evaluation by decision curve analysis. Minerva Urol Nefrol, 68(5): 437-43, 2016.PubMed

  5. Tanaka H, Yoshida S, Komai Y, Sakai Y, Urakami S, Yuasa T, Yamamoto S, Masuda H, Koizumi M, Kohno A, Fukui I, Yonese J, Fujii Y, Kihara K. Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management. Urol Int, 96(1): 65-72, 2016.PubMed

  6. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Ishioka J, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K. Candidate selection for quadrant-based focal ablation through a combination of diffusion-weighted magnetic resonance imaging and prostate biopsy. BJU Int, 117(1): 94-101, 2016.PubMed

  7. Waseda Y, Saito K, Ishioka J et al: Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database Study. Eur Urol Focus, 2: 296-302, 2016. DOI:PubMed

学会発表

欧州泌尿器科学会(European Association of Urology annual congress)
  1. Fujii Y, Kihara K, Tanaka H, Saito K., Yoshida S, Yokoyama M., Ishioka J, Matsuoka Y, Numao N. Bladder-sparing protocol consisting of ow-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Oncological and functional outcome in elderly patients. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  2. Matsuoka Y et al. Impact of PI-RADS version 2 on MRI diagnosis for extracapsular extension of prostate cancer: A multireader study. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  3. Ishioka J et al. When should patients undergo prostate biopsy? Decision analysis using differences in the health-related quality-of-life between pre-biopsy healthy men and patients with castration-resistant prostate cancer. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  4. Kawamura N, Yokoyama M, Fujii Y, Inoue M, Ito M, Yoshida S, Ishioka J, Numao N, Matsuoka Y, Saito K, Kihara K. Longitudinal preservation of renal function after clamp-less partial nephrectomy: An analysis of patients with chronic kidney disease. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  5. Yokoyama M, Kawamura N, Fujii Y, Inoue M, Ishioka J, Numao N, Matsuoka Y, Saito K, Arisawa C, Okuno T, Noro A, Morimoto S, Kihara K. Longitudinal changes in renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter study using a linear mixed model analysis. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  6. Yoshida S et al. The utility of diffusion-weighted MRI as an imaging biomarker of upper urinary tract cancer: A preoperative prognostic indicator reflecting histological grade. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  7. Yoshida S et al. Potential utility of standardized apparent diffusion coefficient value as a biomarker predicting clinical aggressiveness of bladder cancer with various MRI protocols at various institutions. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  8. Inoue M et al. Prediction of therapeutic resistance using ERBB2 expression status and Ki-67 labelling index in muscle-invasive bladder cancer patients treated with chemoradiation-based selective bladder-sparing approach. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

  9. Tanaka H et al. Novel stepwise algorithm using CT and MRI for differential diagnosis of fat-poor angiomyolipoma in small renal masses: Development and external validation. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  10. Moriyama S et al. A new quantitative method for characterizing small renal masses: MRI intensity ratio curve analysis, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  11. Waseda Y. et al. Elevation of urinary metanephrine/normetanephrine and impairment of glucose tolerance predict the development of hypoglycemia after resection of pheochromocytoma, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  12. Nakamura Y et al. Renal dysfunction manifestation in patients with adrenal Cushing's syndrome after adrenalectomy, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/13

  13. Fujiwara M et al. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases, The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/12

  14. Yasuda Y, Saito K, Kawamura N, Yuasa T, Yokoyama M, Matsuoka Y, Ishioka J, Numao N, Okuno T, Yamamoto S, Takahashi S, Yonese J, Fujii Y, Kihara K. Prognostic significance of early CRP response for metastatic renal cell carcinoma treated with tyrosine kinase inhibitor. The 31th Annual Congress of the European Association of Urology, Munich, Germany, 2016/3/14

米国泌尿器科学会(annual meeting of the American Urological Association)
  1. Fujii Y et al. Bladder-sparing protocol consisting of low-dose chemoradiotherapy and consolidative partial cystectomy against muscle-invasive bladder cancer: Comparison of oncological and functional outcomes between older and younger patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  2. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  3. Matsuoka Y et al. Applicability analysis of focal therapy to intermediate- and high-risk prostate cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  4. Matsuoka Y et al. Impact of prebiopsy magnetic resonance imaging (MRI) on preoperative risk stratification for biochemical recurrence after radical prostatectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  5. Matsuoka Y et al. Impact of the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) on the assessment of extracapsular extension in prostate cancer: A multireader study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  6. Ishioka J et al. The incidence of late bladder tumor recurrence of upper tract urothelial carcinoma and optimal cystoscopic follow-up: A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  7. Ishioka J et al. Prognostic impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma. A multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  8. Ishioka J et al. Yokoyama M., Kawamura N., Fujii Y., Inoue M., Ishioka J., Numao N., Matsuoka Y., Saito K., Arisawa C., Okuno T., Noro A., Morimoto S., Kihara K. Longitudinal renal function recovery after radical nephrectomy and risk factors for postoperative severe renal impairment: a Japanese multicenter study. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/8

  9. Yoshida S et al. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  10. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  11. Ito M et al. Likelihood of underlying Lynch syndrome in Japanese upper tract urothelial carcinoma patients. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  12. Tanaka H et al. Development and validation of a novel stepwise algorithm using CT and MRI for diagnosis of fat-poor angiomyolipoma in small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  13. Nakayama T, Kazutaka S, Fujii Y, Waseda Y, Moriyama S, Tanaka H, Kawamura N, Inoue M, Ito M, Yoshida, S, Yokoyama M, Matsuoka Y, Numao N, Kihara K. Association of M2 macrophage invasion with C-reactive protein in renal cell carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  14. Moriyama S et al. MRI intensity ratio curve analysis: a new objective method for characterizing small renal masses. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/9

  15. Waseda Y et al. Impact of elevated urinary metanephrine/normetanephrine and impaired glucose tolerance test on the development of hypoglycemia following removal of pheochromocytoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  16. Kobayashi M et al. Maximum standardized uptake value of 18F-FDG PET/CT predicts survival of patients with advanced urothelial carcinoma. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  17. Nakamura Y et al. Masked renal dysfunction in patients with adrenal Cushing's syndrome manifested by adrenalectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  18. Nakamura Y et al. High specificity of diffusion-weighted MRI in differentiating residual bladder cancer from postoperative changes. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

  19. Fujiwara M et al. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  20. Fukushima H, Nakanishi Y, Kataoka M, Tobisu K, Koga F. Prognostic significance of postoperative skeletal muscle mass recovery in metastatic renal cell carcinoma patients who underwent cytoreductive nephrectomy. The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/7

  21. Nakanishi Y, Fukushima H, Yokoyama M, Kataoka M, Tobisu K, Koga F. Can systematic biopsy be safely omitted in the era of MRI/TRUS-fusion targeted prostate biopsy? The 111th annual meeting of the American Urological Association, San diego, USA, 2016/5/6

国際磁気共鳴医学会(The 24th Annual meeting of International Society for Magnetic Resonance in Medicine, Singapore)
  1. Waseda Y, Yoshida S, Takahara T, Tanaka H, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Fujii Y, and Kihara K . Utility of computed diffusion-weighted imaging for predicting aggressiveness of prostate cancer. 2016/5/9

  2. Yoshida S, Koga F, Tanaka H, Fukushima H, Nakanishi Y, Yokoyama M, Ishioka J, Saito K, Fujii Y, Kihara K. Apparent diffusion coefficient ratio as a potential inter-institutional marker for histological grade of bladder cancer. 2016/5/12

研究会主催

  1. 第9回日本ミニマム創泌尿器内視鏡外科学会、東京、2016年12月18日

研究助成